These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16481281)

  • 1. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation.
    Du CY; Xu EK
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engraftment versus immunosuppression: cost-benefit analysis of immunosuppression after intrahepatic murine islet transplantation.
    Marzorati S; Melzi R; Citro A; Cantarelli E; Mercalli A; Scavini M; Piemonti L
    Transplantation; 2014 May; 97(10):1019-26. PubMed ID: 24770621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice.
    Camirand G; Caron NJ; Asselin I; Tremblay JP
    Transplantation; 2001 Jul; 72(1):38-44. PubMed ID: 11468532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of rat hindlimb allografts following short-course FK506 and mycophenolate mofetil combination therapy.
    Song YX; Muramatsu K; Kurokawa Y; Taguchi T
    Microsurgery; 2005; 25(4):353-9. PubMed ID: 15880483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
    Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
    Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid withdrawal or steroid avoidance in renal transplant recipients: focus on tacrolimus-based immunosuppressive regimens.
    Krämer BK; Krüger B; Mack M; Obed A; Banas B; Paczek L; Schlitt HJ
    Transplant Proc; 2005 May; 37(4):1789-91. PubMed ID: 15919467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression.
    Lee D; Keymeulen B; Hilbrands R; Ling Z; Van de Velde U; Jacobs-Tulleneers-Thevissen D; Maleux G; Lapauw B; Crenier L; De Block C; Mathieu C; Pipeleers D; Gillard P
    Transplantation; 2017 Sep; 101(9):2218-2227. PubMed ID: 27779572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
    Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K
    Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.
    Johnson JD; Ao Z; Ao P; Li H; Dai LJ; He Z; Tee M; Potter KJ; Klimek AM; Meloche RM; Thompson DM; Verchere CB; Warnock GL
    Cell Transplant; 2009; 18(8):833-45. PubMed ID: 19500470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression.
    du Toit D; Muller C; Page B; Louw J
    Microsc Res Tech; 1998 Nov; 43(4):347-55. PubMed ID: 9849976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation].
    Kang H; Hong GX; Wang FB; Chen ZB; Huang QS; Weng YX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):264-7. PubMed ID: 12822367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model.
    Kim JP; Hundepool CA; Friedrich PF; Moran SL; Bishop AT; Shin AY
    Microsurgery; 2018 Jan; 38(1):66-75. PubMed ID: 28792625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients.
    Qu W; Zhu ZJ; Sun LY; Wei L; Liu Y; Zeng ZG
    Transplant Proc; 2016; 48(6):2094-7. PubMed ID: 27569951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy.
    Jones JW; Ustüner ET; Zdichavsky M; Edelstein J; Ren X; Maldonado C; Ray M; Jevans AW; Breidenbach WC; Gruber SA; Barker JH
    Surgery; 1999 Aug; 126(2):384-8. PubMed ID: 10455910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dual, triple, and quadruple oral tacrolimus-based immunosuppression regimens after orthotopic liver transplantation: a randomised comparative study of regimens].
    Lu AW; Zheng SS; Wu J; Liang TB; Wang WL; Shen Y; Zhang M; Shi SH; Wu YS
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3389-92. PubMed ID: 17313848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.